Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin.
about
Heparin in malignant glioma: review of preclinical studies and clinical resultsModulation of Sickle Red Blood Cell Adhesion and its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative.Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.
P2860
Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Suppression of pancreatic canc ...... low molecular weight heparin.
@ast
Suppression of pancreatic canc ...... low molecular weight heparin.
@en
type
label
Suppression of pancreatic canc ...... low molecular weight heparin.
@ast
Suppression of pancreatic canc ...... low molecular weight heparin.
@en
prefLabel
Suppression of pancreatic canc ...... low molecular weight heparin.
@ast
Suppression of pancreatic canc ...... low molecular weight heparin.
@en
P2093
P2860
P1433
P1476
Suppression of pancreatic canc ...... low molecular weight heparin.
@en
P2093
Hung-Yun Lin
Murat Yalcin
Patricia Phillips
Thangirala Sudha
Thiruvengadam Arumugam
Tipu Nazeer
P2860
P356
10.1016/J.CANLET.2014.04.016
P407
P577
2014-04-24T00:00:00Z